Benzinga | Nov 12, 2021 11:03AM EST

Earnings Preview: UroGen Pharma

UroGen Pharma (NASDAQ:URGN) is set to give its latest quarterly earnings report on Monday, 2021-11-15. Here's what investors need to know before the announcement.

Analysts estimate that UroGen Pharma will likely report an Earnings Per Share (EPS) of $-1.29

UroGen Pharma bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed on EPS by -7.87%, which was followed by a 1.57% increase in the share price the next day.

Here's a look at UroGen Pharma's past performance and the resulting price change:

Quarter Q2 2021 Q1 2021 Q4 2020 Q3 2020EPS Estimate -1.27 -1.29 -1.37 -1.49EPS Actual -1.17 -1.17 -1.38 -1.31Price Change % 1.57% -1.17% 10.64% -4.5%

Stock Performance

Shares of UroGen Pharma were trading at $18.81 as of November 11. Over the last 52-week period, shares are down 17.39%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all upcoming earnings announcements, click here to use Benzinga Earnings Calendar.